 |
Novel Acting Thrombolytic (NAT) |
|---|---|
| Trade Name | |
| Orphan Indication | Peripheral arterial occlusion (PAO) |
| USA Market Approval | USA |
| USA Designation Date | 2001-01-26 00:00:00 |
| Sponsor | Nuvelo, Inc. Inc.;201 Industrial Road, Suite 310;San Carlos, California, 94070 |
| |
Novel Acting Thrombolytic (NAT) |
|---|---|
| Trade Name | |
| Orphan Indication | Peripheral arterial occlusion (PAO) |
| USA Market Approval | USA |
| USA Designation Date | 2001-01-26 00:00:00 |
| Sponsor | Nuvelo, Inc. Inc.;201 Industrial Road, Suite 310;San Carlos, California, 94070 |